Donald R. Joseph's most recent trade in Acer Therapeutics Inc was a trade of 30,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 14, 2023.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Acer Therapeutics Inc | Donald R. Joseph | Chief Legal Officer and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
Achieve Life Sciences Inc. | Donald R. Joseph | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 4,400 | 4,400 | - | - | Stock Option (right to buy) | |
Acer Therapeutics Inc | Donald R. Joseph | Chief Legal Officer and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) | |
Achieve Life Sciences Inc. | Donald R. Joseph | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2021 | 3,750 | 3,750 | - | - | Stock Option (right to buy) | |
Acer Therapeutics Inc | Donald R. Joseph | Chief Legal Officer and Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 60,000 | 60,000 | - | - | Employee Stock Option (right to buy) |